Authors:
CLIVE S
CASSIDY J
JODRELL D
ROOS B
GOGGIN T
REIGNER B
Citation: S. Clive et al., INFLUENCE OF THE ANTACID MAALOX((R)) ON THE PHARMACOKINETICS (PK) OF XELODA(TM) IN CANCER-PATIENTS, Annals of oncology, 9, 1998, pp. 630-630
Authors:
CLIVE S
JODRELL D
MACLELLAN A
YOUNG A
MILLER M
CUMMINGS J
SMYTH JF
Citation: S. Clive et al., PHASE-I AND PHARMACOKINETIC STUDY OF ANTAGONIST-G - A BROAD-SPECTRUM NEUROPEPTIDE GROWTH-FACTOR ANTAGONIST USING A RAPID DOSE-ESCALATION STRATEGY, Annals of oncology, 9, 1998, pp. 469-469
Authors:
HOLLINS GW
THOMAS S
LANIGAN DJ
DAHAR N
JODRELL D
KAYE SB
KIRK D
Citation: Gw. Hollins et al., RETROPERITONEAL SURGERY - ITS WIDER ROLE IN THE MANAGEMENT OF MALIGNANT TERATOMA, British Journal of Urology, 77(4), 1996, pp. 571-576
Authors:
BISSETT D
JODRELL D
HARNETT AN
HABESHAW T
KAYE SB
EVANS D
WILLIAMS M
CANNEY PA
Citation: D. Bissett et al., PHASE-I STUDY OF ACCELERATED FEC WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (LENOGRASTIM) SUPPORT, British Journal of Cancer, 71(6), 1995, pp. 1279-1282
Authors:
WISHART GC
BISSETT D
PAUL J
JODRELL D
HARNETT A
HABESHAW T
KERR DJ
MACHAM MA
SOUKOP M
LEONARD RCF
KNEPIL J
KAYE SB
Citation: Gc. Wishart et al., QUINIDINE AS A RESISTANCE MODULATOR OF EPIRUBICIN IN ADVANCED BREAST-CANCER - MATURE RESULTS OF A PLACEBO-CONTROLLED RANDOMIZED TRIAL, Journal of clinical oncology, 12(9), 1994, pp. 1771-1777